1. Home
  2. ATEN vs EVO Comparison

ATEN vs EVO Comparison

Compare ATEN & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo A10 Networks Inc.

ATEN

A10 Networks Inc.

HOLD

Current Price

$17.49

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.34

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATEN
EVO
Founded
2004
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
ATEN
EVO
Price
$17.49
$3.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$21.50
$7.00
AVG Volume (30 Days)
734.7K
253.2K
Earning Date
02-03-2026
11-05-2025
Dividend Yield
1.36%
N/A
EPS Growth
4.68
N/A
EPS
0.69
N/A
Revenue
$284,406,000.00
$887,396,457.00
Revenue This Year
$12.37
N/A
Revenue Next Year
$8.10
$8.52
P/E Ratio
$25.42
N/A
Revenue Growth
10.27
N/A
52 Week Low
$13.81
$2.84
52 Week High
$21.90
$4.80

Technical Indicators

Market Signals
Indicator
ATEN
EVO
Relative Strength Index (RSI) 43.68 61.17
Support Level $17.21 $3.10
Resistance Level $17.98 $3.23
Average True Range (ATR) 0.34 0.08
MACD -0.09 0.04
Stochastic Oscillator 19.53 97.92

Price Performance

Historical Comparison
ATEN
EVO

About ATEN A10 Networks Inc.

A10 Networks Inc is a provider of security and infrastructure solutions for on-premises, hybrid cloud, and edge-cloud environments of its multinational enterprise, communication, cloud and web service provider customers who strive to provide business-critical applications and networks that are secure, available, and efficient. As cyber-attacks increase in volume and complexity, the company integrates security and artificial intelligence (AI) enabled capabilities in its solutions that enable its customers to continue to adapt to market trends in hybrid cloud, AI-ready data centers and the ever-increasing need for high-performance, high availability and low latency. The company generates the maximum of its revenue from Americas.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: